Yuxiang Ma - Concepedia

Author

Yuxiang Ma

Sun Yat-sen University Cancer Center ORCID

Also Known As

Ma, Yuxiang, Y Ma, Y. Ma, YANGRUIJUE MA, YUXIANG MA, Ye-Sen Ma, Yichun Ma, Yincheng Ma, Yu-Xiang MA, Yu-Xiang Ma

254

Publications

Citations

H-Index

Concepts

All Affiliations

Sun Yat-sen University Cancer Center Sun Yat-sen University State Key Laboratory of Oncology in South China Fifth Affiliated Hospital of Sun Yat-sen University Guangzhou Medical University

About

Yuxiang Ma is an author at Sun Yat-sen University Cancer Center specializing in medicine, immunology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	27	2.1K
2	Biochemistry	3	3	120
3	Health Sciences	1	1	18
4	Natural Sciences	1	1	43
5	Allergy	1	1	131

Yuxiang Ma

102

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials Wenfeng Fang, Yunpeng Yang, Yuxiang Ma, The Lancet Oncology MedicineImmunologyPathologyImmune Checkpoint InhibitorNasopharyngeal Carcinoma	2018	495
EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy Wenfeng Fang, Jianwei Zhang, Shaodong Hong, Oncotarget ImmunologyImmune RegulationCell DeathImmunotherapeuticsImmunotherapy	2014	382
Comprehensive Genomic Profiling Identifies Novel Genetic Predictors of Response to Anti–PD-(L)1 Therapies in Non–Small Cell Lung Cancer Wenfeng Fang, Yuxiang Ma, Jiani C. Yin, Clinical Cancer Research	2019	235
Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer Sheng Jin, Wenfeng Fang, Juan Yu, Scientific Reports	2016	200
Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibition Xuanye Zhang, Yixin Zhou, Chen Chen, Journal for ImmunoTherapy of Cancer	2019	175
Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung Cancer Ting Zhou, Jianhua Zhan, Shaodong Hong, Scientific Reports	2015	160
Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma Jianwei Zhang, Wenfeng Fang, Tao Qin, Medical Oncology MedicineImmunologyPathologyCancer GenomicsImmune Checkpoint Inhibitor	2015	139
Network Meta-Analysis of Erlotinib, Gefitinib, Afatinib and Icotinib in Patients with Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations Wenhua Liang, Xuan Wu, Wenfeng Fang, PLoS ONE	2014	133
Upregulation of PD-L1 by EML4-ALK fusion protein mediates the immune escape in ALK positive NSCLC: Implication for optional anti-PD-1/PD-L1 immune therapy for ALK-TKIs sensitive and resistant NSCLC patients Shaodong Hong, Nan Chen, Wenfeng Fang, OncoImmunology ImmunologyCell DeathImmunotherapyCancer BiologyTumor Biology	2015	131
The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients Shaodong Hong, Ting Zhou, Wenfeng Fang, Tumor Biology	2014	126

Page 1